Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients

This is the protocol for a review and there is no abstract. The objectives are as follows: This review aims to evaluate the benefits and harms of different routes, frequencies and doses of epoetins (epoetin-α, epoetin-β and other short-acting epoetins) for anaemia in adults and children with predialysis CKD.